Statens Serum Institut (SSI) consists of a management board, four health priority areas and staff units – all with their own departments.

SSI - Organisation chart

See the organisation chart as a pdf.

Management board

Henrik Ullum (CEO)
Ole Jensen (Executive Vice President)
Helle Birk Krogsgaard (Chief Financial Officer)
Anne-Marie Vangsted (TestCenter Danmark)
Tyra Grove Krause (Executive Vice President ad interim) 


Corporate Affairs
Center for Biosecurity & Biopreparedness 

Business Support & Campus (Helle Birk Krogsgaard, Chief Financial Officer)

Business Development
QA & Compliance

Infectious Disease Preparedness (Tyra Grove Krause, Executive Vice President ad interim)

Infectious Disease Preparedness
Infectious Disease Epidemiology & Prevention
Bacteria, Parasites & Fungi
Virus & Microbiological Special Diagnostics
International Reference Laboratory of Mycobacteriology
Prediagnostics & Service

Biobank & Biomarkers (David Hougaard, Executive Vice President ad interim)

Biobank & Biomarkers
Congenital Disorders
Danish National Biobank

Research - vaccines 

Infectious Disease Immunology
Vaccine Development

Research - epidemiology (N.N., Executive Vice President)

Epidemiology research